India's Pharmaceutical Exports

Country Profile

Kazakhstan

Kazakhstan is a growing market for Indian pharmaceuticals — $89.1M in FY 2025–26, with 1.7× growth over the past decade. Medicines accounts for 83% of shipments, with vaccines contributing $3.46M. The compound annual growth rate since FY2015 stands at 4.8%.

🇰🇿 $89.1M · 1.7× growth since FY2015 · 4.8% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$89.1M
Exports FY2025–26 DGCIS
1.7×
Growth FY2015→2026
4.8%
CAGR FY2015→2026
83%
Medicines Share
5
Product Categories Supplied
Kazakhstan is a growing market for Indian pharmaceuticals — $89.1M in FY 2025–26, with 1.7× growth over the past decade. Medicines accounts for 83% of shipments, with vaccines contributing $3.46M. The compound annual growth rate since FY2015 stands at 4.8%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $74.3M (83.5%) Traditional & Herbal $8.13M (9.1%) Vaccines $3.46M (3.9%) Surgical & Hospital Supplies $1.57M (1.8%) Medicine Ingredients $1.57M (1.8%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Kazakhstan in the RBI overseas direct investment dataset (2011–2026).